"AstraZeneca COVID 19 Vaccine"

Latest news and video coverage curated from trusted media outlets


0 shares	Share Tweet Save Post Send



GP nurse receives Oxford-AstraZeneca vaccine at surgery Nurse Sue Toye, 51, is believed to be the first person to receive the Oxford-AstraZeneca Covid-19 vaccine in a GP practice in England having had the jab atPriory Gate Surgery in the City of Coventry.. Credit: PA - Press Association STUDIO Duration: 00:46Published 2 weeks ago

Covid-19: First vaccine shots likely on January 13th, countdown begins\|Oneindia News Indians can expect to get their first COVID-19 vaccine shot on January 13. Union Health Ministry announced on Tuesday that the Centre is all set to roll out coronavirus vaccines within 10 days of.. Credit: Oneindia Duration: 01:00Published 2 weeks ago

'Who will opt for vaccine...': Congress questions approval, slams govt Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid.. Credit: HT Digital Content Duration: 03:25Published 2 weeks ago

UK inoculates first patient with Oxford/AstraZeneca COVID-19 vaccine The UK began distributing the Oxford/AstraZeneca COVID-19 vaccine on Monday after becoming the first country to authorise it. Credit: Euronews English Duration: 01:37Published 2 weeks ago

Boris Johnson urges parents to send kids to school Britain will have 530,000 doses of the Oxford/AstraZeneca COVID-19 vaccine ready to administer on Monday and hopes to provide "tens of millions" of vaccinations over the next three months, Prime.. Credit: Reuters - Politics Duration: 01:28Published 2 weeks ago

UK Becomes First Country to Authorize Oxford-AstraZeneca COVID-19 Vaccine U.K. Becomes First Country to Authorize Oxford-AstraZeneca COVID-19 Vaccine. On Wednesday, the United Kingdom gave emergency authorization to the COVID-19 vaccine developed by the University of.. Credit: Wibbitz Top Stories Duration: 01:25Published 3 weeks ago

UK first to approve AstraZeneca/Oxford vaccine The Oxford University-AstraZeneca COVID-19 vaccine approved by Britain on Wednesday provides a path out of the pandemic by the spring, by which time millions of vulnerable people will be protected,.. Credit: Reuters Studio Duration: 01:32Published 3 weeks ago

UCHealth estimates a thousand participants in AstraZeneca COVID-19 vaccine trial by next week Doctors at UCHealth tell Denver7 that by Monday, they estimate over a thousand people from the Rocky Mountain region will be participating in their AstraZeneca COVID-19 vaccine study. Credit: 7News - The Denver Channel Duration: 02:00Published on December 12, 2020

Nations press on with AstraZeneca vaccine amid concerns Britain asked its regulator on Friday to assess AstraZeneca's COVID-19 vaccine for a possible rollout, while the Philippines and Thailand secured millions of doses, giving the shot a vote of confidence.. Credit: Reuters Studio Duration: 02:01Published on November 27, 2020

Astrazeneca Covid-19 vaccine: Company to run new tests amid fresh doubts Credit: FRANCE 24 English Duration: 01:33Published on November 27, 2020

San Diegans can participate in AstraZeneca Coronavirus vaccine trial San Diegans can participate in AstraZeneca's COVID-19 vaccine trial, which recently showed 90 percent effectiveness under a certain dosage Credit: ABC 10 News \| San Diego Duration: 02:12Published on November 24, 2020

South Florida doctor optimistic about AstraZeneca COVID-19 vaccine Encouraging news on Monday on a vaccine for the coronavirus. Drug maker AstraZeneca reported its vaccine in an overseas trial is showing somewhere between 62% and 90% effective. Credit: WPTV News \| West Palm Beach Duration: 01:49Published on November 23, 2020

How AstraZeneca COVID-19 Vaccine Compares To Moderna, Pfizer AstraZeneca said that late-stage trials show its COVID-19 vaccine is up to 90-percent effective. Dr. Mallika Marshall reports. Credit: WBZ CBS Boston Duration: 03:00Published on November 23, 2020

Dow Jumps 210 Points On Vaccine News From AstraZeneca On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug.. Credit: Wochit Duration: 00:38Published on November 23, 2020

You Might Like

Pakistan approves emergency use of Oxford-AstraZeneca COVID-19 vaccine In the first phase, the vaccine will be given to health workers and those aged 65 years and above, Mr. Umar said. Hindu - Published 2 days ago
Astrazeneca vaccine gets approval in Pakistan Astrazeneca's Covid-19 vaccine has been granted approval for emergency use in Pakistan, the country's health minister said on Saturday, the first vaccine against the disease to be given the green light.. IndiaTimes - Published 3 days ago
India wants Serum Institute to lower price of AstraZeneca shot, say sources The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme... IndiaTimes - Published 1 week ago

Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loom Brazilian President Jair Bolsonaro asked Prime Minister Narendra Modi to expedite a shipment of AstraZeneca's Covid-19 vaccine amid broader delays to the vaccine's arrival in Brazil, according to a.. IndiaTimes - Published 1 week ago
UK dialysis patient among first to be vaccinated by Oxford-AstraZeneca COVID-19 vaccine The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against COVID-19, with an 82-year-old Oxford-born dialysis.. Mid-Day - Published 2 weeks ago
'Covishield' ready to roll out in coming weeks: Poonawalla Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after.. IndiaTimes - Published 2 weeks ago

What you need to know about Oxford COVID-19 vaccine With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon as a meeting of the decision-making body.. Mid-Day - Published 3 weeks ago
UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute IndiaTimes - Published 3 weeks ago
Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: Report The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups. Hindu - Published 3 weeks agoAlso reported by •Mid-Day
Serum Institute seeks emergency use nod for Covishield Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. "As promised, before the end of 2020, @SerumInstIndia has applied.. Mid-Day - Published on December 7, 2020

COVID-19: After Pfizer, Pune-based SII seeks emergency use approval for Covishield vaccine in India SII on Sunday applied to the DCGI seeking emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine in the country. Zee News - Published on December 7, 2020
Citing tech issues, UN COVID-19 summit nixes Adar Poonawalla video The United Nations Covid-19 summit passed up a pre-recorded video message from Adar Poonawalla, CEO of the world's largest vaccine manufacturer, who was scheduled to speak in an afternoon session.. Mid-Day - Published on December 5, 2020
One crore healthcare workers will be 1st to get COVID-19 vaccine: Government An estimated one crore frontline health workers will receive the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of private.. Mid-Day - Published on December 4, 2020	SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is.. Mid-Day - Published on November 28, 2020
Britain asks regulator to assess Oxford/AstraZeneca COVID-19 vaccine Indian Express - Published on November 27, 2020	India to consider clinical trials data of two full doses of AstraZeneca vaccine India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which.. IndiaTimes - Published on November 26, 2020
1 crore healthcare workers to receive COVID-19 vaccine in first phase: Report An estimated one crore frontline health workers will receive the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of private.. Mid-Day - Published on November 25, 2020	AstraZeneca COVID-19 vaccine can be 90% effective, results show Indian Express - Published on November 23, 2020Also reported by •Hindu
Adar Poonawalla's SII aims to have 100m doses of AstraZeneca vaccine ready by December Serum Institute of India (SII) is ramping up production of AstraZeneca's Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that.. Mid-Day - Published on November 14, 2020	India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccine Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival.. IndiaTimes - Published on November 12, 2020
Production of AstraZeneca COVID-19 vaccine begins in Australia newKerala.com - Published on November 9, 2020	Oxford COVID vaccine prompts immune response among adults: AstraZeneca The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults British drugmaker AstraZeneca Plc said on Monday. DNA - Published on October 26, 2020
AstraZeneca COVID-19 vaccine trial back on track in US; Johnson & Johnson to follow AstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies.. DNA - Published on October 24, 2020	AstraZeneca COVID-19 vaccine trial volunteer in Brazil dies Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would.. Zee News - Published on October 22, 2020Also reported by •Indian Express •Hindu
Coronavirus \| AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue Brazilian newspaper O Globo reported that the volunteer had been given a placebo and not the trial vaccine, citing unnamed sources Hindu - Published on October 21, 2020Also reported by •Indian Express	Astrazeneca Covid-19 vaccine trial in US expected to resume as early as this week Indian Express - Published on October 20, 2020
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine. DNA - Published on September 26, 2020

"AstraZeneca COVID 19 Vaccine"

Latest news and video coverage curated from trusted media outlets

You Might Like

Pakistan approves emergency use of Oxford-AstraZeneca COVID-19 vaccine

Astrazeneca vaccine gets approval in Pakistan

India wants Serum Institute to lower price of AstraZeneca shot, say sources

Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loom

UK dialysis patient among first to be vaccinated by Oxford-AstraZeneca COVID-19 vaccine

'Covishield' ready to roll out in coming weeks: Poonawalla

What you need to know about Oxford COVID-19 vaccine

UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute

Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: Report

Serum Institute seeks emergency use nod for Covishield

COVID-19: After Pfizer, Pune-based SII seeks emergency use approval for Covishield vaccine in India

Citing tech issues, UN COVID-19 summit nixes Adar Poonawalla video

One crore healthcare workers will be 1st to get COVID-19 vaccine: Government

SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla

Britain asks regulator to assess Oxford/AstraZeneca COVID-19 vaccine

India to consider clinical trials data of two full doses of AstraZeneca vaccine

1 crore healthcare workers to receive COVID-19 vaccine in first phase: Report

AstraZeneca COVID-19 vaccine can be 90% effective, results show

Adar Poonawalla's SII aims to have 100m doses of AstraZeneca vaccine ready by December

India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccine

Production of AstraZeneca COVID-19 vaccine begins in Australia

Oxford COVID vaccine prompts immune response among adults: AstraZeneca

AstraZeneca COVID-19 vaccine trial back on track in US; Johnson & Johnson to follow

AstraZeneca COVID-19 vaccine trial volunteer in Brazil dies

Coronavirus | AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

Astrazeneca Covid-19 vaccine trial in US expected to resume as early as this week

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla